Taken as a once-weekly injection, tirzepatide is often chosen by women who want a stronger effect on appetite, or who have plateaued on another GLP-1
Management: Rotate sites, use smaller insulin syringes, and keep injection volume low (0.5 mL) Potential for IGF-1 Resistance or Downregulation Using IGF1 LR3 continuously without breaks can desensitize IGF1 receptors , reducing effectiveness over time
They generally do not work for compounded medications from specialty or compounding pharmacies
When you eat, your body releases GLP-1, which tells your brain youre full, slows stomach emptying, and helps regulate blood sugar by triggering insulin release
Someone injecting 3-4 times daily encounters far more opportunities for reactions than someone injecting once weekly
The additives do not change tirzepatide half-life or accumulation characteristics